These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16012931)

  • 21. Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection.
    Glover DK; Ruiz M; Takehana K; Petruzella FD; Riou LM; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA
    Circulation; 2001 Sep; 104(10):1181-7. PubMed ID: 11535577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.
    Glover DK; Riou LM; Ruiz M; Sullivan GW; Linden J; Rieger JM; Macdonald TL; Watson DD; Beller GA
    Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1851-8. PubMed ID: 15591104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons.
    Cassada DC; Tribble CG; Long SM; Kaza AK; Linden J; Rieger JM; Rosin D; Kron IL; Kern JA
    Ann Thorac Surg; 2002 Sep; 74(3):846-9; discussion 849-50. PubMed ID: 12238849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease.
    Olson TS; Bamias G; Naganuma M; Rivera-Nieves J; Burcin TL; Ross W; Morris MA; Pizarro TT; Ernst PB; Cominelli F; Ley K
    J Clin Invest; 2004 Aug; 114(3):389-98. PubMed ID: 15286805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of systemic and retrograde delivery of adenosine A2A agonist for attenuation of spinal cord injury after thoracic aortic cross-clamping.
    Reece TB; Okonkwo DO; Ellman PI; Maxey TS; Tache-Leon C; Warren PS; Laurent JJ; Linden J; Kron IL; Tribble CG; Kern JA
    Ann Thorac Surg; 2006 Mar; 81(3):902-9. PubMed ID: 16488692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis.
    Rivera-Nieves J; Bamias G; Vidrich A; Marini M; Pizarro TT; McDuffie MJ; Moskaluk CA; Cohn SM; Cominelli F
    Gastroenterology; 2003 Apr; 124(4):972-82. PubMed ID: 12671894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1.
    Matsuzaki K; Tsuzuki Y; Matsunaga H; Inoue T; Miyazaki J; Hokari R; Okada Y; Kawaguchi A; Nagao S; Itoh K; Matsumoto S; Miura S
    Clin Exp Immunol; 2005 Apr; 140(1):22-31. PubMed ID: 15762871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model.
    McPherson JA; Barringhaus KG; Bishop GG; Sanders JM; Rieger JM; Hesselbacher SE; Gimple LW; Powers ER; Macdonald T; Sullivan G; Linden J; Sarembock IJ
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):791-6. PubMed ID: 11348876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted inhibition of heat shock protein 90 suppresses tumor necrosis factor-α and ameliorates murine intestinal inflammation.
    Collins CB; Strassheim D; Aherne CM; Yeckes AR; Jedlicka P; de Zoeten EF
    Inflamm Bowel Dis; 2014 Apr; 20(4):685-94. PubMed ID: 24552830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of PSGL-1 attenuates CD14+ monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice.
    Inoue T; Tsuzuki Y; Matsuzaki K; Matsunaga H; Miyazaki J; Hokari R; Okada Y; Kawaguchi A; Nagao S; Itoh K; Matsumoto S; Miura S
    J Leukoc Biol; 2005 Mar; 77(3):287-95. PubMed ID: 15569697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-5 participates in the pathogenesis of ileitis in SAMP1/Yit mice.
    Takedatsu H; Mitsuyama K; Matsumoto S; Handa K; Suzuki A; Takedatsu H; Funabashi H; Okabe Y; Hara T; Toyonaga A; Sata M
    Eur J Immunol; 2004 Jun; 34(6):1561-9. PubMed ID: 15162425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commensal bacteria exacerbate intestinal inflammation but are not essential for the development of murine ileitis.
    Bamias G; Okazawa A; Rivera-Nieves J; Arseneau KO; De La Rue SA; Pizarro TT; Cominelli F
    J Immunol; 2007 Feb; 178(3):1809-18. PubMed ID: 17237431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta7 integrin deficiency suppresses B cell homing and attenuates chronic ileitis in SAMP1/YitFc mice.
    Gorfu G; Rivera-Nieves J; Hoang S; Abbott DW; Arbenz-Smith K; Azar DW; Pizarro TT; Cominelli F; McDuffie M; Ley K
    J Immunol; 2010 Nov; 185(9):5561-8. PubMed ID: 20926792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice.
    Mitsuyama K; Matsumoto S; Rose-John S; Suzuki A; Hara T; Tomiyasu N; Handa K; Tsuruta O; Funabashi H; Scheller J; Toyonaga A; Sata M
    Gut; 2006 Sep; 55(9):1263-9. PubMed ID: 16682432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis.
    Naganuma M; Wiznerowicz EB; Lappas CM; Linden J; Worthington MT; Ernst PB
    J Immunol; 2006 Sep; 177(5):2765-9. PubMed ID: 16920910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection.
    Chhabra P; Wang K; Zeng Q; Jecmenica M; Langman L; Linden J; Ketchum RJ; Brayman KL
    Cell Transplant; 2010; 19(5):597-612. PubMed ID: 20350347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Inflammatory Effect of Dietary Pentadecanoic Fatty Acid Supplementation on Inflammatory Bowel Disease in SAMP1/YitFc Mice.
    Singh D; Mehghini P; Rodriguez-Palacios A; Di Martino L; Cominelli F; Basson AR
    Nutrients; 2024 Sep; 16(17):. PubMed ID: 39275347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse.
    McNamee EN; Wermers JD; Masterson JC; Collins CB; Lebsack MD; Fillon S; Robinson ZD; Grenawalt J; Lee JJ; Jedlicka P; Furuta GT; Rivera-Nieves J
    Inflamm Bowel Dis; 2010 May; 16(5):743-52. PubMed ID: 19856411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease.
    Bamias G; Marini M; Moskaluk CA; Odashima M; Ross WG; Rivera-Nieves J; Cominelli F
    J Immunol; 2002 Nov; 169(9):5308-14. PubMed ID: 12391251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.